Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSLPE.L Regulatory News (SLPE)

  • There is currently no data for SLPE

Quarterly Trading Statement

24 Mar 2017 07:00

RNS Number : 3655A
Standard Life Private Eqty Trst PLC
24 March 2017
 

Standard Life Private Equity Trust PLC

 

1. Investment update for the quarter ended 31 December 2016

 

· The Company's net asset value per ordinary share ("NAV") increased by 4.3% to 361.2p for the quarter ended 31 December 2016

· Realised gains and income during the quarter ended 31 December 2016 were £18.5 million (3.5% of NAV). The unrealised gains on the portfolio on a constant exchange rate basis were £9.7 million (1.8% of NAV); in addition, there were unrealised foreign exchange losses of £3.6 million (0.7% of NAV)

· 100.0% by value of the portfolio was valued by the respective underlying managers at 31 December 2016

· Outstanding commitments were £312.5 million at 31 December 2016

· Liquid resources were £107.4 million at 31 December 2016

 

For the quarter ended 31 December 2016 the Company's NAV increased by 4.3% to 361.2p, from 346.4p at 30 September 2016. At 31 December 2016 the Company's net assets were £555.3 million (30 September 2016 - £532.6 million). NAV total return was 4.3% for the quarter from 1 October 2016 to 31 December 2016.

 

The closing value of the Company's portfolio of 50 private equity fund interests was £447.9 million at 31 December 2016 (30 September 2016 - £433.4 million and 49 private equity fund interests). The total unrealised gains on the portfolio for the quarter ended 31 December 2016 were £6.1 million, comprising £9.7 million of unrealised gains on a constant exchange rate basis and £3.6 million of unrealised foreign exchange losses. The MSCI Europe Index and the FTSE All Share Index (both in sterling) rose by 4.4% and 3.1% respectively during the quarter. The unrealised foreign exchange losses were driven by the Euro depreciating by 1.4% relative to sterling over the quarter.

 

During the quarter ended 31 December 2016 the Company received £30.8 million of distributions (quarter ended 31 December 2015 - £45.1 million) and funded £20.3 million of draw downs (quarter ended 31 December 2015 - £17.0 million). The distributions received during the quarter generated £18.5 million of net realised gains and income, which was equivalent to a return of 2.5 times the acquisition cost of the realised investments.

 

The Company made one new fund commitment of €34.0 million to the IK VIII Fund. The Company also agreed to acquire, through a secondary purchase, an original commitment of €20.0 million to Nordic Capital VII. The purchase price for the fund interest was €22.1 million, equivalent to a small premium of 2.0% to the most recent valuation date of 30 September 2016, adjusted for subsequent cashflows. The Company assumed outstanding commitments of £0.9 million on acquisition. The Company has existing commitments of €15.0 million and €30.0 million to Nordic Capital Fund VII and VIII respectively. This transaction completed on 12 January 2017.

 

The Company had total outstanding commitments to its 50 private equity fund interests of £312.5 million at 31 December 2016 (30 September 2016 - £305.9 million and 49 private equity fund interests). The Manager continues to believe that around £55 million of the Company's existing outstanding commitments are unlikely to be drawn.

 

At 31 December 2016 the Company had liquid resources of £107.4 million comprised of cash and cash equivalents (30 September 2016 - liquid resources of £105.9 million). The Company continues to have an undrawn £80 million syndicated revolving credit facility provided by Citibank and Societe Generale that expires in December 2020.

 

 

2. Activity since 31 December 2016

 

On 27 January 2017 the Company paid a final dividend for the year ended 30 September 2016 of 3.6p per ordinary share (total for the year of 5.4p per ordinary share). The cost of the final dividend was £5.5 million.

 

During the period from 1 January to 10 March 2017 the Company received £21.8 million of distributions and funded £14.1 million of draw downs.

 

A new commitment of £22.0 million was also made to HgCapital 8 on 15 February.

 

At 10 March 2017 the Company had liquid resources of £91.5 million. The Company also had total outstanding commitments of £326.6 million.

 

The Company's estimated NAV at 28 February 2017 is also being announced today. It is anticipated that the Company will release its results for the six months ending 31 March 2017 on or around 8 June 2017.

 

 

For further information please contact:-

 

Roger Pim at SL Capital Partners LLP (0131 245 0055)

 

Note:-

Standard Life Private Equity Trust PLC is an investment company managed by SL Capital Partners LLP, the ordinary shares of which are admitted to listing by the UK Listing Authority and to trading on the Stock Exchange and which seeks to conduct its affairs so as to qualify as an investment trust under sections 1158-1165 of the Corporation Tax Act 2010. The Board of Standard Life Private Equity Trust PLC is independent of Standard Life plc.

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTZXLFLDXFLBBD
Date   Source Headline
10th Apr 201410:41 amRNSHolding(s) in Company
2nd Apr 201410:07 amRNSDirector Declaration
1st Apr 201411:39 amRNSTotal Voting Rights
19th Mar 20147:00 amRNSQuarterly Trading Statement
3rd Mar 201410:00 amRNSTotal Voting Rights
3rd Feb 201412:20 pmRNSTransaction in Own Shares
3rd Feb 201410:58 amRNSTotal Voting Rights
29th Jan 20144:05 pmRNSTransaction in Own Shares
28th Jan 20142:29 pmRNSHolding(s) in Company
28th Jan 20142:27 pmRNSInterim Management Statement
28th Jan 20142:22 pmRNSResult of AGM
24th Jan 20144:41 pmRNSTransaction in Own Shares
2nd Jan 201412:01 pmRNSQuarterly Disclosure
2nd Jan 201411:59 amRNSTotal Voting Rights
31st Dec 20139:55 amRNSApplication for Listing
11th Dec 20134:51 pmRNSTransaction in Own Shares
4th Dec 20134:31 pmRNSAnnual Financial Report
28th Nov 20137:00 amRNSPreliminary Results
31st Oct 20132:40 pmRNSApplication for Listing
1st Oct 20139:57 amRNSQuarterly Disclosure
23rd Sep 201311:48 amRNSDirector Declaration
18th Sep 20137:00 amRNSQuarterly Trading Statement
1st Aug 20137:30 amRNSTotal Voting Rights
11th Jul 20136:14 pmRNSHolding(s) in Company
8th Jul 201312:28 pmRNSInterim Management Statement
1st Jul 201310:58 amRNSQuarterly Disclosure
28th Jun 201311:46 amRNSApplication for Listing
21st Jun 20139:47 amRNSDirector Declaration
11th Jun 20134:03 pmRNSDirectorate Change
3rd Jun 20131:58 pmRNSDirectorate Change
29th May 20135:00 pmRNSHalf Yearly Report
2nd Apr 201311:43 amRNSQuarterly Disclosure
2nd Apr 201311:40 amRNSTotal Voting Rights
26th Mar 20134:58 pmRNSTransaction in Own Shares
20th Mar 20134:05 pmRNSDirector/PDMR Shareholding
20th Mar 20137:00 amRNSQuarterly Trading Statement
18th Mar 20133:25 pmRNSHolding(s) in Company
8th Feb 20132:41 pmRNSDirector/PDMR Shareholding
5th Feb 20131:20 pmRNSDirector/PDMR Shareholding
1st Feb 201311:33 amRNSTotal Voting Rights
29th Jan 20134:37 pmRNSInterim Management Statement
29th Jan 20131:52 pmRNSIssue of Equity
29th Jan 20131:48 pmRNSResult of AGM
29th Jan 20131:47 pmRNSDirectorate Changes
9th Jan 20134:29 pmRNSScrip dividend reference price
4th Jan 201312:22 pmRNSQuarterly Disclosure
3rd Jan 201311:21 amRNSDirector/PDMR Shareholding
31st Dec 20128:00 amRNSApplication for Listing
31st Dec 20128:00 amRNSDebt Facility
14th Dec 201212:15 pmRNSDoc re. Annual Report and Circular

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.